DBVT

DBVT

USD

DBV Technologies S.A. American Depositary Shares

$8.720-0.250 (-2.787%)

Цена в режиме реального времени

Healthcare
Биотехнология
Франция

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$8.970

Максимум

$9.046

Минимум

$8.720

Объем

0.01M

Фундаментальные показатели компании

Рыночная капитализация

252.2M

Отрасль

Биотехнология

Страна

France

Статистические данные торговли

Средний объем

0.44M

Биржа

NCM

Валюта

USD

52-недельный диапазон

Минимум $0.441Текущая $8.720Максимум $12.78

Связанные новости

GlobeNewswire

DBV Technologies to Participate in Upcoming EAACI Congress 2025

Châtillon, France, June 12, 2025 DBV Technologies to Participate in Upcoming EAACI Congress 2025 DBV Technologies (TRQX:DBVp), a clinical-stage biopharmaceutical company, today announced upcoming participation in the

Просмотреть больше
DBV Technologies to Participate in Upcoming EAACI Congress 2025
GlobeNewswire

DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting

Châtillon, France, June 11, 2025 DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (TRQX:DBVp), a clinical-stage

Просмотреть больше
DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting
GlobeNewswire

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025

Information regarding the total number of voting rights and total number of shares of the Company as of May 30, 2025 (Article 223-16 of the General Regulations of

Просмотреть больше
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025
GlobeNewswire

DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document

Châtillon, France, June 03, 2025 DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBV Technologies (TRQX:DBVp), a clinical-stage biopharmaceutical company (the

Просмотреть больше
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
Analyst Upgrades

JMP Securities Maintains Market Outperform on DBV Technologies, Raises Price Target to $21

JMP Securities analyst Jonathan Wolleben maintains DBV Technologies with a Market Outperform and raises the price target from $15 to $21.

Просмотреть больше
JMP Securities Maintains Market Outperform on DBV Technologies, Raises Price Target to $21

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.